Insider filing · RCUS
Jennifer Jarrett
Chief Operating Officer
profile →
Arcus Biosciences, Inc.
RCUS · Healthcare · 21 filings in 24 months
ticker →
Jennifer Jarrett sold $467K of Arcus Biosciences (RCUS)
Executed Dec 16 2025, disclosed Dec 18 2025, 2 days later.
Value, as filed
$467K
21,208 sh across 2 lots
Executed
Dec 16 2025
the trade date, as filed
Disclosed
Dec 18 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JJJennifer Jarrett (Chief Operating Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Arcus Biosciences, Inc. (RCUS). The largest single filing was $954K of RCUS (50,291 sh × $18.97, as filed), executed Nov 7 2025.
The name
RCUSHealthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jennifer Jarrett in RCUS
RCUSSALE
Arcus Biosciences, Inc.
$954K50,291 sh × $18.97
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. $751K
50,292 sh across 2 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET